Candriam Luxembourg S.C.A. lowered its stake in HCA Holdings Inc. (NYSE:HCA) by 11.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 156,694 shares of the company’s stock after selling 19,689 shares during the period. Candriam Luxembourg S.C.A.’s holdings in HCA Holdings were worth $12,068,000 as of its most recent filing with the SEC.
Several other institutional investors also recently bought and sold shares of HCA. Acrospire Investment Management LLC bought a new position in HCA Holdings during the first quarter valued at about $109,000. NN Investment Partners Holdings N.V. bought a new position in HCA Holdings during the first quarter valued at about $148,000. Invictus RG raised its position in HCA Holdings by 21.9% in the first quarter. Invictus RG now owns 2,156 shares of the company’s stock valued at $168,000 after buying an additional 388 shares during the last quarter. Bremer Trust National Association bought a new position in HCA Holdings during the second quarter valued at about $239,000. Finally, Parametrica Management Ltd bought a new position in HCA Holdings during the second quarter valued at about $273,000. Institutional investors own 72.83% of the company’s stock.
HCA Holdings Inc. (NYSE:HCA) traded down 1.59% during midday trading on Monday, reaching $74.91. The company had a trading volume of 2,991,684 shares. HCA Holdings Inc. has a 12-month low of $60.07 and a 12-month high of $83.69. The firm has a market capitalization of $28.36 billion, a price-to-earnings ratio of 12.98 and a beta of 0.82. The stock’s 50 day moving average is $75.79 and its 200 day moving average is $77.53.
HCA Holdings (NYSE:HCA) last issued its earnings results on Thursday, July 28th. The company reported $1.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.56 by $0.10. The business earned $10.32 billion during the quarter, compared to the consensus estimate of $10.49 billion. HCA Holdings had a negative return on equity of 42.19% and a net margin of 5.75%. The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.37 earnings per share. Equities research analysts expect that HCA Holdings Inc. will post $6.59 earnings per share for the current year.
Several equities analysts have recently issued reports on HCA shares. Mizuho restated a “buy” rating and set a $102.00 target price on shares of HCA Holdings in a research report on Thursday, July 14th. Zacks Investment Research upgraded HCA Holdings from a “hold” rating to a “buy” rating and set a $85.00 target price for the company in a research report on Tuesday, July 5th. Credit Suisse Group AG restated a “buy” rating on shares of HCA Holdings in a research report on Tuesday, June 28th. Finally, Jefferies Group reiterated a “buy” rating on shares of HCA Holdings in a research report on Wednesday, August 10th. Eight research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $86.88.
HCA Holdings Company Profile
HCA Holdings, Inc is a healthcare services company. The Company’s segment is operating hospitals and related healthcare entities. The Company operates approximately 168 hospitals, consisting of 164 general, acute care hospitals; three psychiatric hospitals, and one rehabilitation hospital. In addition, the Company operates approximately 116 freestanding surgery centers.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings Inc. (NYSE:HCA).
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.